secwatch.observer — SEC 8-K summary
======================================

Issuer:     CEL SCI CORP (CVM)
CIK:        0000725363
Form:       8-K
Filed at:   2022-08-08T23:59:59+00:00
Accession:  0001654954-22-010767
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

CEL-SCI appoints Gail K. Naughton, Ph.D. to Board of Directors
--------------------------------------------------------------

- Dr. Naughton founded Advanced Tissue Sciences (ATIS) and Histogen (HSTO), with 35+ years in regenerative medicine.
- She holds over 125 U.S. and foreign patents and received the National Inventor of the Year award in 2000.
- She serves on boards of Therapeutics MD (TXMD) and chairs the La Jolla Institute for Immunology board.
- Appointment effective August 2, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/725363/000165495422010767/0001654954-22-010767-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/725363/000165495422010767/cvm_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-22-010767

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer